Chem. Pap.
3-(3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)-N’-((3-
(benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-
cyanoacrylohydrazide (13)
(100). Anal. Calcd. for C27H17N3O2 (415.44): C, 78.06; H,
4.12; N, 10.11%. Found: C, 78.23; H, 4.40; N, 10.35%.
Synthesis of 3-(3-(benzofuran-2-yl)-1-phenyl-1H-pyrazol-
A
mixture of 12 (0.37 g, 1.00 mmol), 1 (0.29 g,
4-yl)-2-cyanoprop-2-enethioamide (6)
1.00 mmol), piperidine (0.3 mL, 3.04 mmol), and dry
EtOH (30 mL) was refluxed for 1 h. The solid product
formed on cooling was collected by filtration and dried to
give pure 13 (0.51 g, 0.80 mmol; 80%). Mp 237–238 °C.
IR (KBr) mmax/cm-1 1598 (C=O), 2223 (CN), 3280 (NH).
1H NMR: d 7.41–8.10 (m, 20H, Ar–H), 8.45 (s, 1H, CH),
8.56 (s, 1H, CH), 8.95 (s, 1H, CH-pyrazole), 9.34 (s, 1H,
CH-pyrazole), 11.13 (s, exch., 1H, NH). 13C NMR: 158.0,
155.2, 154.9, 150.2, 147.4, 145.7, 143.0, 141.4, 140.4,
139.9, 136.3, 130.3, 130.23, 130.19, 129.0, 128.8, 128.0,
126.9, 126.2, 125.7, 125.5, 123.9, 123.3, 119.5, 118.8,
111.7, 108.3, 106.7, 106.6. MS (EI) m/z (%): 640 (M? ? 1,
42), 639 (M?, 100). Anal. Calcd. for C39H25N7O3 (639.66):
C, 73.23; H, 3.94; N, 15.33%. Found: C, 73.47; H, 4.09; N,
15.52%.
Method A A mixture of 3 (0.83 g, 2.00 mmol), 4 (0.2 g,
2.00 mmol), piperidine (0.3 mL, 3.04 mmol), and dry
EtOH (30 mL) was refluxed for 5 h. The solid obtained
was filtrated, dried, and crystallized from DMF to give pure
6 (0.53 g, 1.44 mmol; 72%). Mp 205–206 °C. IR (KBr)
1
m
max/cm-1 1342 (C=S), 2213 (CN), 3286–3343 (NH2). H
NMR: d 7.34–8.00 (m, 10H, Ar–H), 8.48 (s, 1H, CH), 9.43
(s, 1H, CH-pyrazole), 10.22 (s, exch., 2H, NH2). 13C NMR:
d 106.9, 111.6, 114.8, 116.8, 119.4, 119.7, 121.9, 123.7,
125.7, 127.9, 127.9, 128.3, 129.5, 129.8, 129.9, 137.8,
138.5, 144.9, 147.7, 154.5, 191.4. MS (EI) m/z (%): 371
(M? ? 1, 43), 370 (M?, 56), 57 (100). Anal. Calcd. for
C21H14N4OS (370.43): C, 68.09; H, 3.81; N, 15.12%.
Found: C, 68.32; H, 3.98; N, 15.53%. Selected crystallo-
graphic data: orange plates, C21H14N4OS, FW = 370.42,
Synthesis of 15 A mixture of 1 (0.29 g, 1.00 mmol), 14
(1.00 mmol), piperidine (0.3 mL, 3.04 mmol), and dry
EtOH (30 mL) was refluxed for 2 h. The solid formed on
cooling was filtrated and dried to give pure 15.
˚
T = 296(2) k, k = 0.71073 A, triclinic, space group P1,
˚
a = 5.8807(8) A, b = 9.2390(11) A, c = 16.4270(2) A,
˚
˚
a = 89.882(10)°, b = 82.806(10)°, c = 77.795(11)°,
V = 865.2(2) A , Z = 2, qcalc. = 1.421 Mg/m-3, crystal
3
˚
size = 0.45 9 0.29 9 0.03 mm,
m = 0.021 mm-1
,
3-(3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)-2-
cyano-N’-(1-(furan-2-yl)ethylidene)acrylohydrazide (15a)
reflections collected = 3550,
independent
reflec-
tions = 5319, R = 0.075, wR = 0.196, R(int) = 0.033.
CDC1531680.
Yield 84% (0.39 g, 0.84 mmol); Mp 235–237 °C. IR (KBr)
m
max/cm-1 1608 (C=O), 2220 (CN), 3240 (NH). 1H NMR: d
Method B A mixture of 1 (0.57 g, 2.00 mmol), 4 (0.2 g,
2.00 mmol), piperidine (0.3 mL, 3.04 mmol), and dry
EtOH (30 mL) was refluxed for 3 h. The solid obtained
was filtrated, dried, and crystallized from EtOH to give
pure 6 (0.61 g, 1.64 mmol; 84%). The spectroscopic and
analytical data were similar to those obtained for 6 using
method A.
2.36 (s, 3H, CH3), 6.89–7.97 (m, 13H, Ar–H), 8.53 (s, 1H,
CH), 9.35 (s, 1H, CH-pyrazole), 10.55 (s, exch., 1H, NH).13C
NMR: d 11.7, 103.9, 106.2, 109.1, 110.8, 115.8, 111.6, 112.9,
119.3, 121.3, 123.3,124.6, 125.1, 126.2, 127.2, 127.8, 129.4,
137.9, 139.7, 141.6, 143.2, 144.9, 147.4 153.9, 190.2. MS (EI)
m/z (%): 462 (M? ? 1, 100), 461 (M?, 35). Anal. Calcd. for
C27H19N5O3 (461.47): C, 70.27; H, 4.15; N, 15.18%. Found:
C, 70.38; H, 4.31; N, 15.37%.
N’-((3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-
yl)methylene)-2-cyanoacetohydrazide (12)
3-(3-(Benzofuran-2-yl)-1-phenyl-1H-pyrazol-4-yl)-N’-(1-
(benzofuran-2-yl)ethylidene)-2-cyanoacrylohydrazide
(15b)
A
mixture of 1 (1.44 g, 5.00 mmol), 11 (0.50 g,
5.00 mmol), glacial AcOH (0.5 mL, 8.74 mmol), and dry
MeOH (20 mL) was refluxed for 1 h. The formed solid was
collected by filtration and dried to give pure 12 (1.53 g,
4.14 mmol; 83%). Mp 215–217 °C (lit 228–230 °C;
Abdel-Aziem 2015). IR (KBr) mmax/cm-1 1686 (C=O),
Yield 86% (0.41 g, 0.86 mmol); Mp 240-242 °C. IR (KBr)
m
max/cm-1 1605 (Cld=O), 2218 (CN), 3228 (NH). 1H
NMR: d 2.35 (s, 3H, CH3), 7.28–8.00 (m, 15H, Ar–H), 8.67
(s, 1H, CH), 9.30 (s, 1H, CH-pyrazole), 11.05 (s, exch., 1H,
NH). 13C NMR: d 11.9, 103.8, 106.3, 110.8, 114.3, 119.3,
121.3, 122.9, 123.1, 123.1, 125.1, 127.2, 127.3, 127.8,
129.0, 129.4, 137.9, 144.2, 147.2, 147.4, 152.8, 159.9,
190.4. MS (EI) m/z (%): 512 (M? ? 1, 100). Anal. Calcd.
for C31H21N5O3 (511.53): C, 72.79; H, 4.14; N, 13.69%.
Found: C, 72.99; H, 4.37; N, 13.96%.
1
1612 (C=N), 2215 (CN), 3282 (NH). H NMR: d 4.21 (s,
2H, CH2), 7.39–8.10 (m, 10H, Ar–H), 8.61 (s, 1H, CH),
9.33 (s, 1H, CH-pyrazole), 11.78 (s, exch., 1H, NH). MS
(EI) m/z (%): 370 (M? ? 1, 100), 369 (M?, 85). Anal.
Calcd. for C21H15N5O2 (369.38): C, 68.28; H, 4.09; N,
18.96%. Found: C, 68.39; H, 4.18; N, 19.21%.
123